Nano PharmaSolutions, Inc. (NPS) officially launched its US operation on August 25th. NPS’ facility is located in San Diego’s Life Science hub of Sorrento Valley. Supporters and San Diego-based pharmaceutical professionals attended in the Grand Opening event on Tuesday, 8/25/20 to celebrate this momentous occasion. Dr. Kay Olmstead (CEO/Co-Founder) presented updates regarding the company’s progress towards commercial operation and an overview of its transformative technology platform. Luigi Schioppi (VP/Development) gave a tour of the recently acquired facility.

The tour highlighted the upgraded office/boardroom area, the 500 square feet analytical laboratory and the pharmaceutical-intermediate production area where the Phase Transformer resides. When convenient, please review the article authored by Silvia Mah (AdAstra/Stella Lab) at https://www.linkedin.com/feed/update/urn:li:activity:6704561097602686976/ Her article, which originally was posted on LinkedIn, has received over 3000 views within 48 hours.

Silvia Mah and Dr. Kay Olmstead in front of the Phase Transformer

New laboratory of Nano PharmaSolutions, Inc. (Sorrento Valley – San Diego)

NPS’s phase-transition technology platform, for maximizing the solubility of BCS 2 and BCS 4 active pharmaceutical ingredients (API), is more environmentally-friendly, reliable, straightforward and easier to implement (think quicker to FDA-mandated preclinical and first-in-human clinical trials) than spray dry dispersion (SDD), hot melt extrusion (HME) or chemically produced nano formulations. NPS technology platform does not involve the use of chemicals or solvents to generate nano particles and will not cause thermal degradation of API. Please consult our LinkedIn company profile for updates regarding our important new pharmaceutical methodology offering.